Synaptic vesicle glycoprotein 2C enhances vesicular storage of dopamine and counters dopaminergic toxicity

Meghan L. Bucher,Amy R. Dunn,Joshua M. Bradner,Kristen Stout Egerton,James P. Burkett,Michelle A. Johnson,Gary W. Miller

DOI: https://doi.org/10.1111/ejn.16311

IF: 3.698

2024-03-28

European Journal of Neuroscience

Abstract:The synaptic vesicle glycoprotein 2C (SV2C) works in concert with the vesicular monoamine transporter 2 (VMAT2) to regulate vesicular dopamine dynamics. Because of the leaky nature of synaptic vesicles, substrate (e.g. FFN206, dopamine, MPP+) will leak out over time, decreasing the vesicular content. Blocking VMAT2 through inhibition results in an increase in the amount of substrate lost over time because of a loss of reuptake capabilities. A lack of SV2C expression similarly results in an increase in the amount of substrate lost over time. The cumulative loss of substrate over time is exacerbated in conditions with no SV2C expression and VMAT2 inhibition. Dopaminergic neurons of the substantia nigra exist in a persistent state of vulnerability resulting from high baseline oxidative stress, high‐energy demand, and broad unmyelinated axonal arborisations. Impairments in the storage of dopamine compound this stress because of cytosolic reactions that transform the vital neurotransmitter into an endogenous neurotoxicant, and this toxicity is thought to contribute to the dopamine neuron degeneration that occurs Parkinson's disease. We have previously identified synaptic vesicle glycoprotein 2C (SV2C) as a modifier of vesicular dopamine function, demonstrating that genetic ablation of SV2C in mice results in decreased dopamine content and evoked dopamine release in the striatum. Here, we adapted a previously published in vitro assay utilising false fluorescent neurotransmitter 206 (FFN206) to visualise how SV2C regulates vesicular dopamine dynamics and determined that SV2C promotes the uptake and retention of FFN206 within vesicles. In addition, we present data indicating that SV2C enhances the retention of dopamine in the vesicular compartment with radiolabelled dopamine in vesicles isolated from immortalised cells and from mouse brain. Further, we demonstrate that SV2C enhances the ability of vesicles to store the neurotoxicant 1‐methyl‐4‐phenylpyridinium (MPP+) and that genetic ablation of SV2C results in enhanced 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP)‐induced vulnerability in mice. Together, these findings suggest that SV2C functions to enhance vesicular storage of dopamine and neurotoxicants and helps maintain the integrity of dopaminergic neurons.

neurosciences